It is well established that persistent infection with the human papillomavirus (HPV) is associated cervical cancer. Large studies have shown that HPV is present in up to 90% of cervical cancers (Bosch et al, 1995). There are many types of HPV, the HPV-16
variety is seen in about half of all cases.
A Swedish case-control study (Wallin et al, 1999) indicates that women with smear tests which are HPV DNA-positive (ie. contain genetic material from the virus) are at increased risk of developing invasive cervical cancer in the future. They found that
women who developed cervical cancer had the same type of HPV DNA in smear tests at and prior to diagnosis. This provides further evidence for a causal association between HPV and cervical cancer. It also indicates that the use of HPV DNA testing
technologies may be a valuable addition to the early detection / prevention of cervical cancer in the future.